Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 457 active entries
19 rue de la Haye
67300 Schiltigheim
France Phone: +33 3 90 20 54 70
Fax: +33 3 88 56 16 88
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Description:
ProteoGenix is a leading biotechnology company specializing in custom antibody development for therapeutic, diagnostic, and research applications. Managing the entire process, from antigen production to antibody generation, ProteoGenix employs advanced methods such as hybridoma development, phage display, and single B cell sorting. The company excels in comprehensive antibody characterization and sophisticated antibody engineering, ensuring high affinity, specificity, and stability of the antibodies produced. For clients seeking recombinant antibody production, ProteoGenix offers both transient and stable cell line development. Proprietary cell lines are optimized for high-yield expression, providing scalable and cost-effective solutions for large-scale antibody production. A client-centric approach is at the heart of ProteoGenix's operations. The team works closely with clients to understand their unique challenges and objectives, designing and implementing tailored strategies that deliver exceptional results. Experienced scientists and experts provide personalized support and guidance throughout the development process. ProteoGenix's commitment to innovation is evident in its continuous investment in research and development to stay ahead of the latest advancements in antibody technologies. ISO-certified facilities and stringent quality control measures ensure that every project is executed to the highest standards, delivering antibodies that meet and exceed client expectations in terms of performance and reliability. In addition to custom services, ProteoGenix offers a catalog of over 11,000 research bioreagents, providing clients with a wide range of tools to support their scientific endeavors. Building long-term partnerships with pharmaceutical companies, biotech firms, and research institutions worldwide, ProteoGenix combines comprehensive services with a dedication to quality and client satisfaction. The result is solutions that drive success and advance the field of antibody development.
Selected Categories:
Last update of this entry: July 12, 2024
|